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Health care trends and vascular specialists: The
good, the bad, and the ugly
Ralph G. DePalma, MD, Washington, DC
Current health care trends include movements toward general health care reform and rapidly evolving changes affecting
treatment of vascular disease. Government-sponsored programs and private coalitions increasingly influence practice
management and patient care. Emerging organizational influences derive from public perceptions, policies, laws, and
regulations intended to make health care safe, effective, patient centered, timely, efficient, and equitable. These trends
energized methods of quality assessment, cost containment, and practice protocols over individual judgments and seek to
exert increasing direction over clinical practice. Some evolving measures are good, some controversial, and some, without
deliberate intent, may be harmful. This review considers evolving initiatives in the context of ethics of practice and
practicalities of managing patients with vascular disease. Key issues include compliance with purely process-based
measures, pay for performance, and assessment of quality outcomes. Strengths, weaknesses, opportunities, and potential
threats to vascular practice are outlined. (J Vasc Surg 2011;53:1439-45.)
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cLAWS AND TRENDS INFLUENCING HEALTH
CARE REFORM
Governmental influences, laws, regulations, and pay-
ment methods have risen to dominate health care and
medical practice. The concept of government responsibility
for the health of its citizens dates back to Greek city-states
when “public physicians” provided care for presumably
needy citizens.1 The United States, in 1798, established a
Marine Hospital Service instituting a prepaid insurance
program for merchantmen.
While other countries such as Prussia in 1854 andGreat
Britain in 1911 enacted health insurance provisions, it was
not until the Social Security Act of 1935 that the first step in
the United States was taken to initiate programs of public
assistance and medical support for states to provide mater-
nal welfare and children while simultaneously strengthen-
ing the public health service. After extensive debate, the
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doi:10.1016/j.jvs.2010.12.035rst Medicaid bill (Kerr-Mills) became public law in Sep-
ember 1960. The increasing number of elderly people and
scalating health care costs increased public and political
wareness of the need to support health care. Medicare
ame to the fore during 1963 when the pioneering cardio-
ascular surgeon, Michael E. De Bakey, famously visited
resident Kennedy to support this measure over the oppo-
ition and opprobrium of many of his colleagues. He later
arned of unwieldy rigid federal programs and insurance
ndustry bureaucracies, both of which appear as issues
oday.2
By 1965, President Lyndon Johnson succeeded in im-
lementing Public Law 89-97, the Medicare and Medicaid
ct, providing for hospital and medical payments adminis-
ered through the states for the needy and by the federal
overnment for individuals aged 65 years. Payment for
ervices then provided a rationale for control of processes,
osts, and assessing quality of outcomes related to treat-
ent. These considerations increasingly drive current
rends. The United States and Canada had very similar
ealth care systems until Canada reformed its system in the
960s and 1970s to a universal single-payer system cover-
ng most hospital and physician charges.3
One of the consequences of the Medicare program in
he United States was the development of Regional Medi-
al Programs (RMPs) with databases tracking provision of
are. In the 1990s, RMPs were used to study provision of
urgical services. These investigations unearthed unwar-
anted variation in performance of procedures, initially
onsillectomy and hysterectomy unrelated to illness, medi-
al need, or patient preference, first described in Vermont
nd then nationwide.4 As early as 1953, surgical leadership
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May 20111440 DePalmain the United States noted inappropriate surgery.5 Unfor-
tunately, authority to curb these practices did not evolve.
When geographic tracking data became available, initially
from Blue Cross data and then from Medicare RMPs,4 it
became clear that inappropriate surgical procedures were a
problem, concluding that these were dictated by physician
behavior.
As a current example, although carotid endarterectomy
for asymptomatic lesions has been shown by prospective
trial to be beneficial in stroke prevention for patients aged
74 years,6 carotid endarterectomy and stenting have be-
come increasingly contentious issues.7,8 The issue of best
medical therapy vs interventional treatment for carotid
disease will not escape attention; some believe that medical
intervention alone is now best for stroke prevention asso-
ciated with asymptomatic carotid disease.9 A trial of best
medical therapy is underway.10 Carotid endarterectomy
has the potential to become as controversial as tonsillec-
tomy and hysterectomy were in the past.4,5
A series of health care measures, including the Omni-
bus Reconciliation Acts (OBRA) of 1980, 1981, 1986,
1989, 1990, and 1993 had important effects on Medicare
payments to physicians and hospitals, establishing Diagno-
sis Related Group formulas,11 while the Deficit Reduction
Act of 1984 froze physician fees in Medicare and encour-
aged uniform acceptance of fee assignment by expediting
bill payments. All of these measures profoundly affected
practice management by reducing fee-for-service options in
the United States, leading to further oversight and control
of medical practice.
Measures culminating in the American Recovery and
Reinvestment Act of 2009 jump-started the present admin-
istration’s plans for health care to provide funding for
biomedical and comparative effectiveness research (CER),
adoption of health information technology, and protection
of the privacy and security of medical records.12 This pro-
gram, in addition to offering opportunities for research,13
will likely influence practice management, treatment
choices, process development, and imaging technology of
interest to vascular specialists.
In translating CER into clinical practice, it is critical to
know what we do not know before committing to guide-
lines that will potentially inhibit the development of new
procedures, techniques, and instruments. Choices of com-
parative effectiveness are the everyday work of vascular
specialists. They choose specific treatments for individual
patients. At the same time, vascular specialists must partic-
ipate as members of teams working in increasingly inte-
grated and organized health care systems, whether public
or private. As experts, vascular specialists contribute to
technique development, guidelines, outcome criteria, or
benchmarks for acceptable outcomes.
The final implications of the Health Care and Educa-
tion Reconciliation Act passed onMarch 23, 2010, amend-
ing the Patient Protection and Affordable Care Act (PL
111-148) have yet to be fully understood. The history of
laws and regulations and the trends show a clear direction.
Although thesemeasures intend to do good and to improve care, they also pose challenges that did not exist in a
ong-gone laissez-faire environment. Current challenges
or the vascular specialist will be to maintain flexibility, to
ontinue to develop innovative methods of diagnosis, par-
icularly imaging, and to develop increasingly effective in-
erventions. Interventionalists must insist on fair methods
o measure quality and performance and to assess out-
omes. These have yet to be achieved.
Quality assessments are more complex than most real-
ze. Their implementation depends on information tech-
ology (IT). Along with critical analysis of IT methods,
ifferences between recording outcomes and the evolving
iscipline of quality assessment requires further research.14
he process of quality assessment dates back many decades,
et remains in evolution.15,16 Details of quality assessment
n vascular surgery, recently described in another venue,17
ill be briefly considered. The present review focuses upon
trengths, weaknesses, opportunities, and ethical dilemmas
or specialists treating vascular disease.
UALITY ASSESSMENT: PUBLIC AND
RIVATE
Quality assessment requires high reliability IT systems
o gather and aggregate data along with experts to objec-
ively analyze the data. IT systems, beyond simple admin-
strative databases, are ideally coupled with compatible
lectronic medical record systems. Beginning in 1977,
hese two elements came together in the Veterans Health
dministration (VHA), a government-supported health
are system. Many individuals brought this agency to the
orefront of medical computing with a system known as the
eterans Health Information Systems and Technology Ar-
hitecture (VISTA). Its evolution from a decentralized
ystem to a more recent state has been described in detail.18
huri et al19 provided critical elements of a surgical module
o track clinical and safety data. Ongoing efforts to achieve
omputerized patient records occurred simultaneously
ith quality improvement initiatives in cardiac and noncar-
iac surgery, making possible risk-adjusted comparisons for
urgical procedures using multiple preoperative and intra-
perative variables.
When, in 1986, Congress ordered the VA to compare
tself with prevailing national standards for similar proce-
ures,20 the initiative was driven by central direction as well
s by external advisory boards. At the time, “national
revailing standards” did not exist for the public or private
ectors, and to large degree, they still do not. To address
his challenge, beginning in 1991 VHA developed pro-
rams known as the National Surgical Improvement Pro-
ram (NSQIP) and Continuous Improvement in Cardiac
urgery Program. Their implementation coincided with
ontinually improving results in risk-adjusted and aggre-
ate mortality rates.21
In 2009, surgical quality initiatives merged into a single
rogram, the Veterans Administration Surgical Quality
rogram (VASQIP) supported by a single database. The
merican College of Surgeons developed its ACS-NSQIP,
ollaborating with VHA to validate its applicability in the
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Volume 53, Number 5 DePalma 1441private sector and initiated a proprietary private sector
program in 2005. Improved private sector results in partic-
ipating hospitals were reported as reductions in observed-
to-calculated expected mortality and morbidity ratios in
200 facilities,22 among approximately 5000 hospitals
performing surgery in the United States.
Although Donebedian23 described the quality con-
cepts of structure, process, and outcome 50 years ago,
provocative dialogues continue about the details and meth-
ods of surgical quality assessment. Uniform agreement has
yet to be achieved. For example, competing composite
scores have been proposed for evaluating quality of treat-
ment of abdominal aortic aneurysms (AAAs).24 Scoring
might be accomplished in two ways: first, by combining
information across procedures for a measure of aggregate
performance, and second, by combining information across
measures to reflect performance with a single procedure.
Ideas about measuring specific procedures and the concept
of whether to use risk-adjusted vs aggregate mortality and
morbidity for quality assessment persist as issues50 years
later.25
I believe that an optimal approach requires assessment
of both aggregate and risk-adjusted mortality and morbid-
ity. Aggregating multiple episodes of care (some badly
handled and some not) into a single favorable risk-adjusted
statistical report might promote unwarranted complacency.
To be fair and balanced, statistical reporting cannot be
carried to unreasonable extremes. Local peer review of
mortality and morbidity must supplement aggregate re-
ports, detect poor individual performances, and provide the
basis corrective action.
Preoperative demographics (risks) along with effective
and timely referrals within health care systems determine
aggregate or unadjusted mortality rates. These are impor-
tant to surgical outcomes and health care management.
Risk-adjusted mortality reflects surgical performances, cor-
rected for the population vulnerabilities and the health care
system efficiency. The desired end result of vascular inter-
vention is the timely discharge of a well patient without
subsequent readmission, which in itself generally predicts
high mortality. A unique aspect of surgical risk adjustment
is that it is procedure specific: one size does not fit all. This
is particularly so for vascular procedures. Intervention dur-
ing the course of vascular disease, mainly atherosclerosis, is
a singular discipline associated with a high risk.
Measures of quality assessment and pay for perfor-
mance applied to hospitals, medical group practices, sys-
tems of health care, and to doctors are now law. Quality
measures, as recently summarized, are multiple and di-
verse.26 In the United States, quality measures are man-
dated by the Joint Commission on Hospital Accreditation,
which, interestingly, originated within the American Col-
lege of Surgeons founded in 1913. The initial methods for
hospital quality used in 1928 were hospital evaluations
based simply on “end results of outcomes.” In 1951, this
organization joined with the American College of Physi-
cians, The American Hospital Association, and the Ameri-
canMedical Association to create the Joint Commission for gospital Accreditation. The overall policy of the Joint
ommission requires that: “TheHealth Care Organization
as a planned, systematic organizational wide approach to
rocess design and performance measurement, assessment,
nd improvement.”27
Medicare payment requires compliance with the Joint
ommission policy, illustrating how private and public
ntities evolved with the intent of improving hospital and
ealth care organizational quality. Although the Joint
ommission measures are useful for structural analyses,
elevant quantitative measures to assess vascular perfor-
ances along with the reliability of measuring and ensuring
uality or “outcome” performances remain nonspecific28
n most health care systems. Clarification of these linkages
y the vascular community presents an important opportu-
ity for improvement.
Historically, vascular surgeons who were members of
he Cleveland Vascular Society were among the first to
reate a voluntary registry based on society membership.
hese pioneering efforts depended on early use of com-
uter technology to compare individual and group perfor-
ances as well as aggregate information about the efficacy
f particular operations.29,30 Recently, The North Ameri-
an Subfascial Endoscopic Perforator Surgery registry, a
linician-supported society registry,31 first demonstrated
reliminary results and safety of endoscopic perforator sur-
ery for advanced venous disease. The registry findings
rompted trials, eventually providing scientifically based
vidence for more proactive treatment of venous ulcers.32
hus, private voluntary clinician-patient driven efforts for
uality improvement can be quite effective.26 Speciality
utreach programs, multisite quality improvement collab-
rations, and management of chronic conditions for pro-
essional education and development offer substantial op-
ortunities to improve care of patients with vascular
isease.
In contrast, manager/policy–driven quality initiatives
nclude hospital- or system-sponsored quality improve-
ent programs, system re-engineering, redesign of whole
ystems, safety improvement programs, models of contin-
ous care, public scorecards, external accreditation, net-
orks of like-minded institutions, and guidelines for clini-
al governance. Scott26 highlighted the heterogeneity of
uality improvement systems, methodologic flaws in assess-
ng validity, and difficulties in generalizing results system
ide. This was the bad news. The good news is that
linician-patient–driven quality improvement systems, par-
icularly driven by professional organizations, might be
ore effective than manager/policy–driven systems if rig-
rously monitored and well supported. The main issues
ith voluntary initiatives are financial support, inadvertent
iases, and the challenges of unassailable data acquisition,
eduction, and analysis.
Berwick33 underscored a need to develop more formal
nalytic methods. The view that prospective randomized
ontrolled trials provide a sole standard for evidence-based
edicine must be examined. Level 1 recommendations are
enerally based on randomized controlled trials applicable
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May 20111442 DePalmato patients receiving a uniform treatment alternative for a
relatively singular disease entity medically treated using a
single drug.34 Even in these cases, we now know that some
trials may stand on clay feet.
The debate about randomized trials to justify use of
endovascular interventions by comparing open and endo-
vascular repair of ruptured aneurysms is instructive.35 Ef-
fective surgical techniques develop as heuristic, iterative
results of problem solving resulting in new solutions with
highly specific modifications that make them increasingly
effective. Clearly, endovascular technology for aortic aneu-
rysms offers short-term and now long-term benefits albeit
at higher cost.36 Veith recently argues that if ruptured
AAAs can be treated by endovascular repair by a skillful
team in an experienced center that it is sensible to do so,
while Veith et al35 call for randomized trials to address this
issue.
A great deal of money can be spent to promote pro-
spective randomized trials. This could become a conflict of
interest and even do harm by insisting on randomized
controlled trials for virtually everything imaginable, for
every technique, and every modification of technique. In
part, this stand is defensive: a wish to compensate for past
criticism for admittedly poor statistical discipline in surgical
case series analyses. Surgical research, in a 1996 Lancet
article37 was labeled “Comic Opera.” The title was
catchy–– this reference is still cited in argument.35 Yet, this
article lauded a trial of small incisions for cholecystectomy
as superior to laparoscopic cholecystectomy, an opinion
that turned out to be exactly wrong. Dogmatic insistence
on a single method of proof poses the risk of our becoming
professional controversialists. A more balanced approach to
the challenges involved in surgical data interpretation has
been recently published.38 With experience and improving
technique, propensity analyses also offer clear advantages
during this era in which new procedures are rapidly evolv-
ing.
For example, VA outcomes of care for vascular surgery
and AAA, since inception of quality monitoring and data
feedback, have been associated with progressive reduction
in mortality and morbidity for all noncardiac surgery and
improved trends in vascular surgery.39 Overall, noncardiac
surgery showed a continual mortality decline from 3.16 in
fiscal year (FY) 1991 to 1.36 in FY 2008; morbidity fell
from a rate of 17.44% to approximately 10% in FY 1996,
remaining at approximately that level until 2006, when it
began to decrease to 8.78% in FY 2008. Vascular surgery
mortality fell during the same interval from 4.7% at baseline
in 1991 to 2.5% in FY 2008; morbidity declined from
29.5% at baseline to its 2008 level of 14.4%, illustrating the
high risks characterizing vascular surgical patients. Risk-
adjusted mortality decreased from 1.2% to 0.7% during this
period. Aneurysm mortality for open procedures fell from
5.1% to 3.9%, while endovascular AAA repair (EVAR)
beginning in 2001 exhibited a mortality reduction from
3.2% to 0.8% as the number of EVARs performed rose from
125 cases in 2001 to 951 during 2008. oThese data, by propensity analyses, demonstrate con-
inual improvement not necessarily attributable to one
uality measurement method or another, but rather to
terative data based on improved intervention strategies.
he Veterans Affairs Open versus Endovascular Repair
OVER) randomized trial, at the same time, demonstrated
quivalence of these two procedures within the VA inte-
rated health care system and will continue to accumulate
ong-term data.40
Bayesian statistics with forward modeling can offer
early warning” quality signals when numbers are low.
lternatively, facility performance modeled on procedural
ata from prior years can detect deviations from expected
rends. Discovery of unfavorable trends can drive “efferent”
roactive quality actions for facility guidance using audits,
ite visits, and informing leadership of the need to develop
orrective action plans. Outcomes of speciality procedures
one in different hospitals can be used to realign system-
ide patient referrals even as new techniques such as endo-
ascular surgery evolve.
Active programs, including team training for preoper-
tive and postoperative briefings41,42 and safety compli-
nce, quality enhancement research initiatives, and external
eer review are all likely related to improved outcomes
uring the quality transformation of one of the largest
ealth care systems in the United States.43 During this
ransformation, simultaneous bottom-up and top-down
pproaches were essential in achieving quantifiable quality
mprovements. Experience based on system safety require-
ents indicates that passive data downloads to caregivers,
ithout specifying benchmark requirements or action
lans, may not be effective. Active change for quality im-
rovement requires active intervention based on outcomes.
uring the last decade, many quality programs have turned
o measuring process compliance rather than outcome.
elieving that process and outcome are always tightly cou-
led, process compliance has been linked to reimburse-
ent. This concept requires scrutiny and critical examina-
ion.
urgical Complication Improvement Project
The Surgical Complication Improvement Project (SCIP)
eeks to reduce surgical complications by supporting evi-
enced-based process measures agreed on by a steering
ommittee of 10 national public and private organizations,
ncluding the Agency for Healthcare Research and Quality,
he American College of Surgeons, the American Hospital
ssociation, the American Society of Anesthesiologists, the
ssociation of PeriOperative Registered Nurses, the Cen-
ers for Disease Control and Prevention, the Centers for
edicare and Medicaid Services (CMS), the Institute for
ealth Care Improvement, the Joint Commission, and the
HA. Certain specific measures, with experience during
heir implementation, have required modification. Details
elated to vascular surgical practice have been described
lsewhere.44 Mainly, the relevant problems for this patient
opulation involved routine use of -blockers,45 tightness
f blood glucose control, and hypothermia, because no
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Volume 53, Number 5 DePalma 1443uniform measure for temperature monitoring has been
agreed on and promulgated. Most SCIP measures are
sound, but research is needed to focus and relate this
program to vascular surgical interventions.
PAY FOR PERFORMANCE
Pay-for-performance (PFP) programs compensate phy-
sicians, groups, and hospitals for achieving or making prog-
ress toward standard benchmarks that the programs define.
This emerging trend is a fundamental change from fee for
service and relates to variances in the observed frequency of
procedures. PFP is now CMS policy for hospitals, physi-
cians, nursing homes, home health agencies, and other
providers. Evidence that PFP improves quality or reduces
cost remains scanty. A cynical view proposes that its real
usefulness is political to help deal with apparently intracta-
ble cost considerations.46
The negative aspects of PFP and its unintended conse-
quences include our still imperfect knowledge of best prac-
tices for common existing conditions: we do not always
know what works best in each case; shortcomings of
evidenced-based trials to unerringly guide decisionmaking for
individuals; group cost/benefit analyses that fail to consider
individual efficacy (eg, guidelines for AAA screening omit-
ting women); failure to attend to patient-centric needs;
required adherence to rigid guidelines; and expenses of
documentation, data aggregation, reporting, and enforce-
ment, which add substantially to health care cost. These
disadvantages, with proper direction, might be overcome
by intelligent management. The “ugly” in the eye of this
beholder includes inhibition of novel or evolving ap-
proaches to serious illnesses, loss of professional initiatives,
unwarranted assumptions that high rates of process com-
pliance equate to good outcomes, and penalties and pun-
ishments for “never happen” complications that might not
be unavoidable when properly risk adjusted.47 A singular
and frightening prospect is the direction of complex med-
ical decisions by low-level functionaries using cookbook
guidelines that have the force of law.
Aligning payment incentives to encourage quality,
cost-efficient care is the essential and laudable rationale of
PFP. More than half the private sector health maintenance
organizations (HMOs) in the United States in 2007 used
PFPs applicable to80% of the country’s HMO enrollees.
Congress mandated that CMS use PFP programs forMedi-
care reimbursement. Two questions occur: (1) Does it
work? (2) Is it fair and balanced? Data remain sparse––few
empiric studies exist, but the qualified answer to the first
query is further studies are needed.47 In the case of PFP for
hospitals for SCIP and other consolidated quality measures.
The answer is a qualified yes,48 recognizing that additional
research and revision or the PFP criteria need clarification.
ETHICS, VALUES, AND THE VASCULAR
SPECIALIST
Clearly, the goal of all involved is better health care and
improved treatment of patients. Ethics is defined as “That
branch of philosophy dealing with values relating to human oonduct, with respect to the rightness and wrongness of
ertain actions and to the goodness and badness of the
otives and ends of such actions.” Practitioners must con-
ider whether medical treatment is deontologic (ie, abso-
ute rules), consequential (ie, favorable consequences), or
ntention-based (ie, the good intentions or virtue of the
ndividuals making decisions). The latter might viewed as a
ious wish framing past ethical values in medicine but
hould not be dismissed completely. In considering the
hilosophy and ethics of medicine, a crucial starting point is
he healing relationship between physician and patient.49
his clinical interaction characterizes medicine as a disci-
line. Medicine is neither solely art nor science. A deonto-
ogic law-based approach could be valid were medicine
ruly scientific and therefore immutable. So far, we are not
here.50
The issue becomes a matter of practical understanding
nd patient-centric application of particular interventions
n the face of developing treatment alternatives. Vascular
pecialists work in sophisticated environments and with
eams. The team approach, critical for modern health care,
annot substitute for the skill of the lead interventionalists.
omeone must be in charge and ultimately responsible.
he individual skill and judgment of the team leader is
ritical. He or she requires and must welcome appropriate
eedback. Owing to variations in presentation, treatment of
omplicated vascular conditions cannot be guided solely by
protocol.” Guided treatment requires specific interactions
ssentially aimed at right healing actions at the right time
or the right patient, based on circumstances as well as best
vidence. The loss of authority to make these decisions will
rove disastrous for vascular surgeons and their patients.
The inexorable demand for cost-effectiveness and qual-
ty poses yet another dilemma. In health care organizational
erms, as stated by Griffith and White26 regarding decision
heory and case management, “Optimal care is achieved
hen the cost of service is exactly equal to the benefit or
alue, ie when every service order contributed more value
han it cost . . .” This thinkingmight drive regulated health
are––a preoccupation, well-intentioned, to attempt to re-
uce the higher costs of advancing technology in health
are, for example, the higher cost of endovascular devices
nd procedures. Cost/benefit analyses involve a ratio of cost
inus benefit over a denominator with a discount rate and
n exponential time factor. When time becomes short (ie,
oward the end of life), cost relative to benefits become very
igh. Small changes in the discount rate, which cannot be
ccurately predicted, also exert profound effects. Cost anal-
ses may be better applied to bridges, tunnels, and high-
ays than to the treatment of human beings. This dilemma
eeds to be confronted head on, particularly for the elderly
uffering from vascular disease.
The strength of vascular specialists is their ability to
ntervene during the course of a chronic disease using
recise techniques of diagnosis and treatment, along with
eing able to observe directly and at first hand the effects of
reatment on blood vessel pathology, survival, and quality
f life. It is important also to recognize that assessing
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May 20111444 DePalmaquality of life is a complicated demand–– sometimes impos-
sible—according to scholars in the field of ethics.51 Weak-
nesses and vulnerabilities of vascular specialists include the
high-risk characteristics of patients with vascular disease,
the need for a high-tech environment in a relatively ad-
vanced health care facility, the lifestyle demands in dealing
with the very sick, the need for reinterventions, and current
contentions over treatment choices.
Opportunities comprise an increasing demand for ser-
vices due to aging populations, an abundance of research
challenges, and the privilege of being custodians of specific
life-saving expertise along with the obligations these privi-
leges entail. Threats, the ugly, include tendencies toward
rigid rulings by overly zealous administrators or “payers”
and passive descent into fixed protocol-driven treatments
and exclusively cost-driven interventions or noninterven-
tions. These threats need to be delineated, confronted, and
productively managed.
The evolution of public and private sector quality pro-
grams will move forward. Assessment of quality measures
needs to improve in scientific rigor. Cost containment will
continue to preoccupy the politicians and the electorate,
except when they or their loved ones fall ill––it is then that
compassion may exert its influence. Rules will multiply
unless restrained by intelligent administrativemanagement.
It is important to recognize that government is an instru-
ment of force. Results are best achieved from the bottom
up and from the top down. The bottom-up activity, at
present, is mainly that of the medical profession, which
requires better coordination and more effective collabora-
tion with political and legal allies. Achieving “fair and
balanced” goals for quality and contingent reimbursements
require the probity and professionalism of all involved.
Vascular surgeons are responsible, obligated, and privi-
leged to intervene at crucial times in their patients’ lives.
They can effectively assess and quantify quality outcomes.
Now they must seek to influence policy to be certain that
their patients receive the best care.
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